INDIA

More in INDIA

• India Inc on the Move 2025: A resounding success in advancing AI-driven smart and sustainable manufacturing

  India Inc On The Move (IIOTM), the flagship corporate event of Rockwell Automation India, was successfully held on February 19, 2025, at Andaz Delhi, Aerocity. Industry leaders, technology visionaries, and innovators gathered to explore the transformative potential of artificial intelligence (AI) and other advanced technologies in accelerating smart and sustainable manufacturing. The discussions focused on how these innovations can revolutionize the Indian manufacturing sector, ultimately contributing an additional trillion dollars to the country’s GDP.

  

• Clinical research entities asked to register by April 1

  Online registration of clinical research organisations is now functional on the SUGAM portal, the Drug Controller General of India (DCGI) said in an order dated March 4. Applications for registration should be submitted only through the SUGAM portal, it said.

  

• Innovation, AI, Trials and India: At the cusp of a global pharma and biotech reset

  India’s evolving role in global pharma and biotech took center stage at BioAsia 2025, highlighting innovation, AI-driven research, and clinical trials. Industry leaders stressed the need for regulatory reforms and competitive strategies to match China’s rapid rise. As AI transforms drug development and CRDMO opportunities grow, the key question remains—will India lead or lag?

  • Exclusive

  

• From cost-based to value-based: an unfathomed solution to rising healthcare challenges

  At the fifth edition of ET Pharma Re-Pharma summit Industry leaders and other stakeholders have stressed upon realigning Indian pharma companies focus from cost to value to address various health crisis in more holistic and sustainable manner. Experts have also underlined the need to focus on research and innovation for developing more indigenous solutions which hold the potential to overcome the pricing challenge.

  • Exclusive

  

• ET Re Pharma Summit | Chief Guest Address by Chandrashekar RangaJoint Drugs Controller (India) CDSCO

  India’s Drug Regulation: Are We on the Right Path?

  

• ET Pharma Summit | Panel Discussion on Bringing the Right Science

  Speakers:Vikrant Shrotriya, Corporate Vice President & Managing Director, Novo Nordisk IndiaAmit Mookim, Chief Executive Officer, Immuneel TherapeuticsAchin Gupta, Global Chief Operating Officer, CiplaDr. Maneesh Paul, Lead Co-Inventor & Program Director - Enmetazobactam R&D, Orchid PharmaPriya Hingorani, Managing Director, Miltenyi Biotech India

  

• ET Re Pharma Summit | Panel Discussion on Understanding the Healthcare Practitioners HCP’s

  Speakers:Dr. Shashank Joshi, Department of Diabetology and Endocrinology, Lilavati Hospital & Research CentreGagandeep Singh, Managing Director and Head of Human Pharma, India, Boehringer IngelheimRachana Acharya, Medical Affairs Head-Innovative Medicine, Johnson & JohnsonDr. Hozie Kapadia, National Vice President, Indian Medical Association HQGoutam Bhattacharya, Chief Executive Officer, Life Sciences Sector Skill Development CouncilSudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance (Moderator)

  

• ET Re Pharma Summit | Panel Discussion on Understanding the Healthcare Practitioners HCP’s

  Speakers:Shyamakant Giri, CEO, Gland PharmaAmit Choudhary, Founder & CEO, Dawaa DostAshutosh Inamdar, Chief Executive Officer, Lupin Life Sciences LimitedPrathiba Raju, Senior Assistant Editor, ET Pharma

  

• ET Re Pharma Summit | Panel Discussion on Cost Based to Value Based: Can Indian Pharma Make a shift

  Speakers:-Sanjiv Navangul, Managing Director & CEO, Bharat Serums and Vaccines Limited-Rehan Khan, Managing Director, MSD India-Amitabh Dube, Country President, Novartis India-Vinay Ranade, Chief Executive Officer, Reliance Lifesciences -Alpana Sharma, Co Founder & Trustee , Cure SMA Foundation Of India (Advocacy Group)-Gautam Khanna, Chief Executive Officer, PD Hinduja Hospital & Medical Research Centre -Vikas Dandekar, Editor (Pharma & Healthcare), ET Prime

  

• CDSCO Implements Parallel Processing to Expedite Clinical Trial Approvals

  Chandrashekar Ranga, Joint Drugs Controller (India), CDSCO, shared that CDSCO has identified key bottlenecks in clinical trial approvals, particularly delays in Subject Expert Committee (SEC) meetings. To address this, CDSCO has introduced a parallel processing system, allowing simultaneous data review and SEC evaluation, significantly reducing approval timelines. However, challenges in data submission persist, requiring better compliance from applicants. To streamline the process further, CDSCO is actively engaging with stakeholders to enhance understanding and ensure approvals align with the 90-day regulatory timeline.

  • Exclusive

  

• Time for Change: Indian Pharma's crucial shift from Cost-based to Value-based

  Amid the rising global consensus for quality and value along with the eternal challenge of affordability and access, the 5th Edition of Re-Pharma Summit will confront some of the critical challenges facing Indian pharma today and will delve into the imperative question: Can the industry shift from a cost-based model to value-based healthcare?

  • Exclusive